Minerva Neurosciences, Inc. (NERV)
NASDAQ·Healthcare·Biotechnology
$2.40
-0.83%
Mkt Cap $55.94M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$10.00
Range $10.00 – $10.00
Implied Upside
+316.7%
Consensus $10.00 vs current $2.40
NASDAQ·Healthcare·Biotechnology
$2.40
-0.83%
Mkt Cap $55.94M
No recent rating data.
Price Target (4 analysts)
$10.00
Range $10.00 – $10.00
+316.7%
Consensus $10.00 vs current $2.40